KIRKLAND, Wash. – July 17, 2019 — GrowLife, Inc. (OTC: PHOT) (“GrowLife” or the “Company”), one of the nation’s most recognized indoor cultivation product and service providers, today announced that the Company has launched a new platform for the Company’s recently majority acquired EZ-CLONE Enterprises, Inc. (EZ-CLONE) cloning and propagation company to serve as the commercial hemp cloning industry’s resource for innovation.
With the increase in demand for hemp clones as the market continues to expand, the new platform, ezclonehemp.com, is now set to be a trusted resource for cultivators to seek products and education on plant cloning and propagation, specifically designed for hemp growers. Easily navigational, the platform serves those who are looking to learn about hemp clones and the products necessary for growing a consistent and high-quality clone. The platform is a user-friendly and detailed way for those who are interested in hemp clones and the EZ-CLONE Pro aeroponics system to explore the commercial hemp clone industry and order products.
“As experts in plant cultivation, we understand that hemp growers are seeking additional information and products that enable them to grow consistent, high-volume hemp plants, and cloning is one of the best ways to achieve this,” said GrowLife CEO Marco Hegyi. “Through this new platform we clearly define the benefits of cloning, visitors can learn more about our products, make purchases and learn how to grow hemp from clones. When growing hemp for use in CBD extraction, consistency and plant viability are the most important factors on the minds of growers. We wanted to launch a platform for these growers that is easy to navigate and helps them understand not only what products EZ-CLONE has, but why hemp clones are necessary and the future of hemp production.”
According to a cannabis statistics company, New Frontier Data, the hemp-derived cannabidiol market is expected to jump to $1.3 billion by 2022, from a $390 million market in 2018.
Disclaimer
All stock recommendations and comments are the opinion of writer.
Investors should be cautious about any and all stock recommendations and should consider the source of any advice on stock selection. Various factors, including personal ownership, may influence or factor into a stock analysis or opinion.
All investors are advised to conduct their own independent research into individual stocks before making a purchase decision. In addition, investors are advised that past stock performance is not indicative of future price action.
You should be aware of the risks involved in stock investing, and you use the material contained herein at your own risk. Neither Market-Advisor.com nor any of its suppliers guarantee its accuracy or validity, nor are they responsible for any errors or omissions which may have occurred. The analysis, ratings, and/or recommendations made by Market-Advisor.com, and/or any of its suppliers do not provide, imply, or otherwise constitute a guarantee of performance.
Market-Advisor.com is comprised of reports, if any, embodying a unique system of stock analysis. Accuracy and completeness cannot be guaranteed. Users should be aware of the risks involved in stock investments. It should not be assumed that future results will be profitable or will equal past performance, real, indicated or implied.
The material on this website are provided for information purpose only. Market-Advisor.com does not accept liability for your use of the website. The website is provided on an “as is” and “as available” basis, without any representations, warranties or conditions of any kind.
